MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$25,499K
Free Cash flow
-$16,832K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from the issuance of co...
Stock-based compensation expense
Amortization of debt issuance co...
Others
Negative Cash Flow Breakdown
Net loss
Change in fair value of sepa, wa...
Change in fair value of continge...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Net loss
-7,648
-9,753
-10,811
-18,663
Allowance for credit losses
-
-
34
96
Depreciation
271
126
163
337
Non-cash lease expense
62
22
197
210
Change in fair value of sepa, warrant and revenue base redemption liabilities
6,469
11
-2,785
-1,312
Change in fair value of contingent earnout liability
-6,406
5,147
-2,524
120
Paid-in-kind interest
0
0
800
-
Stock-based compensation expense
5,088
2,197
3,422
3,512
Allowance for credit losses
74
163
-
-
Loss on disposal of property and equipment
-1
-3
0
-117
Deposits
-
-5
0
0
Amortization of debt issuance costs
632
282
275
492
Accounts receivable
-24
1,591
-497
540
Inventory, net
1,128
-199
-531
-241
Prepaid expenses and other assets
622
-192
129
-777
Non-cash interest expense
-
-
-
584
Operating lease liabilities
-62
-27
-26
-81
Change in fair value of orbimed warrants and revenue base redemption liabilities
-
-
-
147
Trade payables and accrued liabilities
-426
692
1,514
-186
Net cash used in operating activities
-16,609
-2,484
-3,709
-11,819
Purchases of property and equipment
223
41
216
661
Proceeds from disposal of property and equipment
0
0
40
40
Net cash used in investing activities
-223
-41
-176
-621
Proceeds from the issuance of common stock, net of issuance costs
42,625
-211
0
22,211
Common stock issuance costs
-
0
0
1,549
Proceeds from the exercise of stock options for common stock
49
87
88
335
Proceeds from the issuance of common stock through employee stock purchase plan
270
404
-
-
Debt issuance costs
613
0
0
520
Proceeds from the issuance of debt
0
0
0
10,000
Payments on finance lease liabilities
27
3
6
72
Short-swing profit settlement
27
-
-
-
Net cash provided by financing activities
42,331
277
82
30,405
Increase in cash, cash equivalents and restricted cash
25,499
-2,248
-3,803
17,965
Cash, cash equivalents and restricted cash, beginning of period
20,789
23,037
8,875
-
Cash, cash equivalents and restricted cash, end of period
46,288
20,789
23,037
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of common stock,...
$42,625K
(91.91%↑ Y/Y)
Proceeds from the
issuance of common stock...
$270K
Proceeds from the
exercise of stock options...
$49K
(-85.37%↓ Y/Y)
Short-swing profit
settlement
$27K
Net cash provided by
financing activities
$42,331K
(39.22%↑ Y/Y)
Canceled cashflow
$640K
Increase in cash, cash
equivalents and restricted...
$25,499K
(41.94%↑ Y/Y)
Canceled cashflow
$16,832K
Debt issuance costs
$613K
(17.88%↑ Y/Y)
Payments on finance lease
liabilities
$27K
(-62.50%↓ Y/Y)
Stock-based compensation
expense
$5,088K
(44.87%↑ Y/Y)
Amortization of debt issuance
costs
$632K
(28.46%↑ Y/Y)
Depreciation
$271K
(-19.58%↓ Y/Y)
Allowance for credit
losses
$74K
(-22.92%↓ Y/Y)
Non-cash lease expense
$62K
(-70.48%↓ Y/Y)
Accounts receivable
-$24K
(-104.44%↓ Y/Y)
Loss on disposal of
property and equipment
-$1K
(99.15%↑ Y/Y)
Net cash used in
operating activities
-$16,609K
(-40.53%↓ Y/Y)
Net cash used in
investing activities
-$223K
(64.09%↑ Y/Y)
Canceled cashflow
$6,152K
Net loss
-$7,648K
(59.02%↑ Y/Y)
Change in fair value of
sepa, warrant and...
$6,469K
(593.06%↑ Y/Y)
Change in fair value of
contingent earnout...
-$6,406K
(-5438.33%↓ Y/Y)
Purchases of property and
equipment
$223K
(-66.26%↓ Y/Y)
Inventory, net
$1,128K
(568.05%↑ Y/Y)
Prepaid expenses and
other assets
$622K
(180.05%↑ Y/Y)
Trade payables and
accrued liabilities
-$426K
(-129.03%↓ Y/Y)
Operating lease
liabilities
-$62K
(23.46%↑ Y/Y)
Buy us a coffee
TriSalus Life Sciences, Inc. (TLSIW)
TriSalus Life Sciences, Inc. (TLSIW)